GENE NEYTMAN: Open Payments
NPI 1003845801 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 15 payments from 8 companies in 2025. Trend: 2023 $684 · 2024 $386 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $120 |
| Lilly USA, LLC | 4 | $68 |
| Exact Sciences Corporation | 1 | $35 |
| Alkermes, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $15 |
Products named: Rybelsus, MOUNJARO, The Cologuard Plus Collection Kit, VIVITROL, Wegovy, FREESTYLE LIBRE 3, Ozempic, AZMIRO.
Industry payments across FL — which companies pay providers there.
